Skip to content

Evaluating Euphorbia Prostrata and Rubber Band Ligation for Treating Grade-2 Hemorrhoids: A Comparative Study

Comparison of Euphorbia Prostrata and Rubber Band Ligation in Grade 2 Adults Hemorrhoids Patients Quassi Experimental Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084384
Enrollment
210
Registered
2025-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Control Intervention1: NIL: NIL

Sponsors

Varshitha dheep
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Males or females aged 18 to 75 years with grade 2 hemorrhoids. Subjects who have already taken corresponding treatment for grade-2 hemorrhoids. Willing to give written informed consent.

Exclusion criteria

Exclusion criteria: Subjects associated with anal fissure or infective anal pathologies, like cryptitis or proctitis were excluded. Subjects treated with some office procedure in the past were also excluded. Pregnant and lactating women were excluded. Subjects who were using other drugs or underwent any surgical procedures for hemorrhoids. Subjects with the history of any significant cardiac, gastro-intestinal, endocrine, neurological, liver, kidney or physiological disease were excluded. Drug or alcohol dependent. Patients who are under Antiplatelet and Anticoagulant drugs were excluded. Subjects participating in any other clinical trial or using any other investigational drug within 30 days prior to the screening were also excluded.

Design outcomes

Primary

MeasureTime frame
1 Reduction in symptoms Improvement in pain bleeding prolapse and discomfort 2 Treatment success rate Percentage of patients achieving complete symptom relief 3 Recurrence rate Frequency of hemorrhoid recurrence within 6 months post-treatment 4 Adverse events Incidence of treatment related complications (eg pain swelling infection)Timepoint: 1 Reduction in symptoms Improvement in pain bleeding, prolapse and discomfort in 7th day

Secondary

MeasureTime frame
1 Quality of life improvement Assessed using a validated hemorrhoid-specific questionnaire 2 Patient satisfaction score Based on treatment experience & symptom relief 3 Time to symptom relief Duration taken for significant symptom improvement post-treatment 4 Need for additional treatment Proportion of patients requiring retreatment or alternativeTimepoint: 1 Quality of life improvement in 14th day

Countries

India

Contacts

Public ContactVarshitha dheep

SRM Medical College and Research Centre

mgr@srmist.edu.in7598464723

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026